Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prostate specific antigen]

A Koutani1, E Lechevallier, C Coulange

  • 1Service d'Urologie B, Hôpital Avicenne, Rabat, Maroc.

Annales D'Urologie
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Active surveillance of low-grade prostate cancer using the SurACaP Criteria: A multi-institutional series with a median follow-up of 10years.

The French journal of urology·2024
Same author

Active surveillance in favorable intermediate-risk prostate cancer: A single-center experience.

The French journal of urology·2023
Same author

[Bladder augmentation in the era of botulinum toxin: Indications and results].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

Saline bladder infusion vs standard catheter removal in patients with acute urinary retention related to benign prostatic hyperplasia: The BLAPERF Study.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

[Evaluation of the results and feasibility of vibration, diuresis and inversion therapy in the treatment of upper urinary tract stones].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022
Same author

A multi-institutional experience of Micro-percutaneous Nephrolithotomy (MicroPERC) for renal stones: Results and feasibility of day case surgery.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022

Prostate specific antigen (PSA) is a key prostate tissue marker. This review covers PSA metabolism, assays, and its clinical use in diagnosing, staging, and monitoring prostate cancer, plus factors affecting PSA levels.

Area of Science:

  • Urology
  • Oncology
  • Biochemistry

Background:

  • Prostate specific antigen (PSA) is the established gold standard for prostate tissue analysis.
  • Accurate assessment of PSA is crucial for effective prostate cancer management.

Purpose of the Study:

  • To review the metabolism and assay methodologies of PSA.
  • To detail the clinical applications of PSA in prostate cancer diagnosis, staging, and treatment monitoring.
  • To discuss factors that can influence PSA levels.

Main Methods:

  • Comprehensive literature review on prostate specific antigen.
  • Analysis of biochemical pathways and assay techniques for PSA.
  • Evaluation of clinical studies on PSA's role in prostate cancer.

Related Experiment Videos

Main Results:

  • Detailed overview of PSA metabolism and current assay techniques.
  • Established clinical utility of PSA for diagnosis, staging, and treatment response assessment in prostate cancer.
  • Identification of various clinical conditions and factors that can elevate PSA levels.

Conclusions:

  • Prostate specific antigen remains a vital biomarker in prostate cancer care.
  • Understanding PSA metabolism, assays, and influencing factors is essential for accurate clinical interpretation.
  • PSA aids in comprehensive prostate cancer management from diagnosis to treatment monitoring.